Page 2
-
Notorious pharma CEO raises price of another lifesaving drug — from $100 to $80,000
Earlier this year, Shkreli jacked up the price of Daraprim, a drug used by some HIV patients, from $13.50 to $750 per tablet.
-
Martin Shkreli regrets not charging even more for AIDS drug
Shkreli claims his behavior was no different than the CEO of Coca Cola. Drug companies, he added, shouldn’t be held to a different standard.
-
As rival’s version sells well, CEO Martin Shkreli reneges on drug price cut
After weeks of criticism, Turing Pharmaceuticals ultimately decided not to cut the price of their HIV medication, which sells for $750-per-pill.
-
Company that raised AIDS drug price by 5,000% reports $14.6 million loss in just 3 months
The company justified the losses by claiming they’re spending 60% of their revenue on researching drugs — particularly Ketamine.
-
Martin Shkreli’s massively expensive HIV drug now has a $1 competitor
More bad news for “the most hated man in America.”
-
Bernie Sanders rejects donation from AIDS drug price-gouger Martin Shkreli
A donation of $2,700 to the Sanders campaign from Shkreli was promptly handed back to the Whitman-Walker health clinic.
-
Five important facts about Martin Shkreli and the Daraprim drama
The situation isn’t as simple as one little man trying to pull one over on the insurance industry.
-
It’s been 2 weeks since CEO Martin Shkreli promised to lower the price of AIDS drug Daraprim. It’s still the same price.
Well, a 30-day supply purchased at your nearest pharmacy still costs $27,006.
-
Donald Trump calls ‘pharma bro’ Martin Shkreli a ‘spoiled brat’
Trump’s opinion of the CEO who tried to raise the price of a drug used to treat AIDS patients? “He is nothing.”
-
After public outcry, CEO drops price of AIDS drug
Martin Shkreli made headlines this week when he raised the price from $13.50 to $750 a tablet literally overnight.